We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
526
Monster Beverage
MNST
$94.3B
$15.6M 0.03%
626,850
+58,166
+10% +$1.4M
Y
527
DELISTED
Alleghany Corp
Y
$15.5M 0.03%
26,083
+586
+2% +$349K
SHY icon
528
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
$15.5M 0.03%
183,289
+30,135
+20% +$2.55M
COR icon
529
Cencora
COR
$60.6B
$15.5M 0.03%
163,725
+49,132
+43% +$4.38M
HPQ icon
530
HP
HPQ
$24.9B
$15.5M 0.03%
884,565
+585,722
+196% +$10.8M
HCA icon
531
HCA Healthcare
HCA
$87.2B
$15.4M 0.03%
176,638
-1,133
-0.6% -$95.9K
STZ icon
532
Constellation Brands
STZ
$22.2B
$15.4M 0.03%
79,294
+11,812
+18% +$2.1M
WBC
533
DELISTED
WABCO HOLDINGS INC.
WBC
$15.3M 0.03%
120,296
-13,275
-10% -$1.59M
EPAC icon
534
Enerpac Tool Group
EPAC
$1.83B
$15.2M 0.03%
618,355
+74,833
+14% +$1.92M
COL
535
DELISTED
Rockwell Collins
COL
$15.2M 0.03%
144,499
+51,185
+55% +$5.3M
ROST icon
536
Ross Stores
ROST
$80.5B
$15.2M 0.03%
262,655
+17,866
+7% +$1.12M
IHF icon
537
iShares US Healthcare Providers ETF
IHF
$1.26B
$15.2M 0.03%
509,930
-10,585
-2% -$298K
FLEX icon
538
Flex
FLEX
$41.7B
$15.2M 0.03%
1,232,670
+59,390
+5% +$735K
WP
539
DELISTED
Worldpay, Inc.
WP
$15.1M 0.03%
239,070
-21,154
-8% -$1.33M
BLV icon
540
Vanguard Long-Term Bond ETF
BLV
$5.71B
$15.1M 0.03%
162,509
+24,019
+17% +$2.21M
ULTI
541
DELISTED
Ultimate Software Group Inc
ULTI
$15M 0.03%
71,212
+2,166
+3% +$456K
ALXN
542
DELISTED
Alexion Pharmaceuticals
ALXN
$15M 0.03%
122,925
-25,065
-17% -$2.92M
JKHY icon
543
Jack Henry & Associates
JKHY
$10.9B
$14.9M 0.03%
143,931
+7,384
+5% +$737K
WBD icon
544
Warner Bros
WBD
$65.9B
$14.9M 0.03%
577,263
+21,203
+4% +$574K
GAM
545
General American Investors Company
GAM
$1.56B
$14.9M 0.03%
433,546
+8,455
+2% +$287K
TFCFA
546
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$14.9M 0.03%
525,239
-16,648
-3% -$479K
CHRW icon
547
C.H. Robinson
CHRW
$17.4B
$14.8M 0.03%
216,038
-1,803
-0.8% -$128K
GXP
548
DELISTED
Great Plains Energy Incorporated
GXP
$14.6M 0.03%
499,584
-61,593
-11% -$1.79M
BWA icon
549
BorgWarner
BWA
$13.1B
$14.6M 0.03%
392,120
+25,541
+7% +$926K
FXO icon
550
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$14.6M 0.03%
510,457
-42,447
-8% -$1.18M

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.